UPMC to shutter Shadyside center focused on ‘natural healing practices’
UPMC will close its Center for Integrative Medicine — which offers services like acupuncture, chiropractic therapy and medical…
Mounjaro: FDA Approves GLP-1 for Cardiovascular Risk Reduction
Share on PinterestThe FDA has approved Mounjaro for cardiovascular risk reduction in people with type 2 diabetes. Milko…
The Ayurveda Co Shuts Down After Overexpansion Derails Business
SUMMARY D2C ayurvedic beauty brand The Ayurveda Co has shut down after ceasing operations in July 2025 and…
How Thai beauty brand Sudtana brought family herbal remedies to luxury hotels across Asia
Small rituals keep her grounded – a few deep breaths during a hectic day, a reminder that not…
Surge in unapproved GLP-1 drugs alarming poison control, safe medicine advocates – NBC Bay Area
Compounded GLP-1 medications are mixed versions of the popular name brand weight loss drugs like Ozempic. They were…
Yakup Ergün: Social Media ‘BUTs’ Surrounding Daraxonrasib in Pancreatic Cancer
Yakup Ergün, Medical Oncologist at Bower Hospital, shared on X: “Some breakthroughs deserve to be celebrated. Daraxonrasib in pancreatic cancer…
Updated migraine prevention guidelines reflect new drug options
New guidelines released Monday highlight the many new treatments that have hit the market in recent years for…
New pill may outperform semaglutide for weight loss and fat burning
NEWYou can now listen to Fox News articles! A team of researchers led by scientists at the University…
Paracetamol warning to millions of people across UK
People who take paracetamol on a regular basis are being warned, with the drug one of the most…
Mounjaro’s Label Expands; Type 1 Diabetes on the Rise; Testosterone and Afib
The FDA expanded the indication for tirzepatide (Mounjaro) to include reducing the risk of major adverse cardiovascular events…
Best practice for clopidogrel prescribing
After reading this article, you should be able to: Describe clopidogrel’s mechanism of action, including its prodrug status,…
India’s largest drugmaker Sun Pharma inks deal with US govt to supply cheaper medicines to Americans
India’s largest drugmaker Sun Pharmaceutical Industries has reportedly signed an agreement with the US government to extend affordable…